Which has preferable earnings and valuation, EHC or MEDP?

Encompass Health has higher revenue and earnings than Medpace. Encompass Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Encompass Health $5.94B 1.64 $566.20M $5.99 16.35 Medpace $2.53B 5.19 $451.12M $15.91 28.93

Does the media favor EHC or MEDP?

In the previous week, Encompass Health had 3 more articles in the media than Medpace. MarketBeat recorded 12 mentions for Encompass Health and 9 mentions for Medpace. Encompass Health's average media sentiment score of 1.65 beat Medpace's score of 0.93 indicating that Encompass Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Encompass Health 12 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Medpace 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, ELV or MEDP?

Elevance Health has higher revenue and earnings than Medpace. Elevance Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Elevance Health $199.13B 0.42 $5.66B $23.51 16.54 Medpace $2.53B 5.19 $451.12M $15.91 28.93

Is ELV or MEDP more profitable?

Medpace has a net margin of 17.19% compared to Elevance Health's net margin of 2.62%. Medpace's return on equity of 120.89% beat Elevance Health's return on equity. Company Net Margins Return on Equity Return on Assets Elevance Health 2.62% 15.58% 5.57% Medpace 17.19% 120.89% 24.79%

Does the media refer more to ELV or MEDP?

In the previous week, Elevance Health had 16 more articles in the media than Medpace. MarketBeat recorded 25 mentions for Elevance Health and 9 mentions for Medpace. Elevance Health's average media sentiment score of 1.65 beat Medpace's score of 0.93 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 24 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Medpace 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, MEDP or HIMS?

Medpace has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medpace $2.53B 5.19 $451.12M $15.91 28.93 Hims & Hers Health $2.35B 3.49 $128.37M -$0.09 N/A

Does the media refer more to MEDP or HIMS?

In the previous week, Hims & Hers Health had 16 more articles in the media than Medpace. MarketBeat recorded 25 mentions for Hims & Hers Health and 9 mentions for Medpace. Medpace's average media sentiment score of 0.93 beat Hims & Hers Health's score of 0.73 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 12 Very Positive mention(s) 5 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, MEDP or IQV?

IQVIA has higher revenue and earnings than Medpace. IQVIA is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medpace $2.53B 5.19 $451.12M $15.91 28.93 IQVIA $16.31B 1.72 $1.36B $8.07 20.84

Is MEDP or IQV more profitable?

Medpace has a net margin of 17.19% compared to IQVIA's net margin of 8.33%. Medpace's return on equity of 120.89% beat IQVIA's return on equity. Company Net Margins Return on Equity Return on Assets Medpace 17.19% 120.89% 24.79% IQVIA 8.33% 30.50% 6.53%

Does the media prefer MEDP or IQV?

In the previous week, IQVIA had 1 more articles in the media than Medpace. MarketBeat recorded 10 mentions for IQVIA and 9 mentions for Medpace. IQVIA's average media sentiment score of 0.96 beat Medpace's score of 0.93 indicating that IQVIA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IQVIA 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, WCN or MEDP?

Waste Connections has higher revenue and earnings than Medpace. Medpace is trading at a lower price-to-earnings ratio than Waste Connections, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waste Connections $9.47B 4.13 $1.08B $4.10 37.57 Medpace $2.53B 5.19 $451.12M $15.91 28.93

Is WCN or MEDP more profitable?

Medpace has a net margin of 17.19% compared to Waste Connections' net margin of 10.97%. Medpace's return on equity of 120.89% beat Waste Connections' return on equity. Company Net Margins Return on Equity Return on Assets Waste Connections 10.97% 16.49% 6.45% Medpace 17.19% 120.89% 24.79%

Does the media favor WCN or MEDP?

In the previous week, Waste Connections had 4 more articles in the media than Medpace. MarketBeat recorded 13 mentions for Waste Connections and 9 mentions for Medpace. Medpace's average media sentiment score of 0.93 beat Waste Connections' score of 0.65 indicating that Medpace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waste Connections 6 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Medpace (MEDP) Competitors

$460.20 0.00 (0.00%)

Closing price 06/18/2026 04:00 PM Eastern

Extended Trading

$449.50 -10.70 (-2.33%)

As of 06/18/2026 07:43 PM Eastern

Compare

MEDP vs. EHC, ELV, HIMS, IQV, and WCN

Should you buy Medpace stock or one of its competitors? MarketBeat compares Medpace with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Medpace include Encompass Health (EHC), Elevance Health (ELV), Hims & Hers Health (HIMS), IQVIA (IQV), and Waste Connections (WCN).

How does Medpace compare to Encompass Health?

Encompass Health (NYSE:EHC) and Medpace (NASDAQ:MEDP) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

Encompass Health has higher revenue and earnings than Medpace. Encompass Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Encompass Health	$5.94B	1.64	$566.20M	$5.99	16.35
Medpace	$2.53B	5.19	$451.12M	$15.91	28.93

Encompass Health currently has a consensus target price of $143.86, indicating a potential upside of 46.89%. Medpace has a consensus target price of $467.08, indicating a potential upside of 1.50%. Given Encompass Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Encompass Health is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Encompass Health	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.00
Medpace	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20

97.3% of Encompass Health shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 1.8% of Encompass Health shares are held by company insiders. Comparatively, 20.5% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Encompass Health had 3 more articles in the media than Medpace. MarketBeat recorded 12 mentions for Encompass Health and 9 mentions for Medpace. Encompass Health's average media sentiment score of 1.65 beat Medpace's score of 0.93 indicating that Encompass Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Encompass Health	12 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Medpace	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Encompass Health has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market. Comparatively, Medpace has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

Medpace has a net margin of 17.19% compared to Encompass Health's net margin of 10.04%. Medpace's return on equity of 120.89% beat Encompass Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Encompass Health	10.04%	18.28%	8.27%
Medpace	17.19%	120.89%	24.79%

Summary

Encompass Health beats Medpace on 9 of the 17 factors compared between the two stocks.

How does Medpace compare to Elevance Health?

Elevance Health (NYSE:ELV) and Medpace (NASDAQ:MEDP) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

Elevance Health has higher revenue and earnings than Medpace. Elevance Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.42	$5.66B	$23.51	16.54
Medpace	$2.53B	5.19	$451.12M	$15.91	28.93

Elevance Health currently has a consensus target price of $416.11, indicating a potential upside of 7.03%. Medpace has a consensus target price of $467.08, indicating a potential upside of 1.50%. Given Elevance Health's stronger consensus rating and higher possible upside, research analysts plainly believe Elevance Health is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61
Medpace	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, Elevance Health had 16 more articles in the media than Medpace. MarketBeat recorded 25 mentions for Elevance Health and 9 mentions for Medpace. Elevance Health's average media sentiment score of 1.65 beat Medpace's score of 0.93 indicating that Elevance Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	24 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Medpace	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 20.5% of Medpace shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Elevance Health has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market. Comparatively, Medpace has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market.

Medpace has a net margin of 17.19% compared to Elevance Health's net margin of 2.62%. Medpace's return on equity of 120.89% beat Elevance Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
Medpace	17.19%	120.89%	24.79%

Summary

Elevance Health beats Medpace on 9 of the 16 factors compared between the two stocks.

How does Medpace compare to Hims & Hers Health?

Medpace (NASDAQ:MEDP) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

Medpace has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, indicating that its share price is 137% more volatile than the broader market.

78.0% of Medpace shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 20.5% of Medpace shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Medpace has a net margin of 17.19% compared to Hims & Hers Health's net margin of -0.56%. Medpace's return on equity of 120.89% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.19%	120.89%	24.79%
Hims & Hers Health	-0.56%	6.10%	1.52%

Medpace has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	5.19	$451.12M	$15.91	28.93
Hims & Hers Health	$2.35B	3.49	$128.37M	-$0.09	N/A

Medpace presently has a consensus price target of $467.08, suggesting a potential upside of 1.50%. Hims & Hers Health has a consensus price target of $29.37, suggesting a potential downside of 17.14%. Given Medpace's stronger consensus rating and higher possible upside, analysts plainly believe Medpace is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20
Hims & Hers Health	3 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.06

In the previous week, Hims & Hers Health had 16 more articles in the media than Medpace. MarketBeat recorded 25 mentions for Hims & Hers Health and 9 mentions for Medpace. Medpace's average media sentiment score of 0.93 beat Hims & Hers Health's score of 0.73 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	12 Very Positive mention(s)	5 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Medpace beats Hims & Hers Health on 13 of the 15 factors compared between the two stocks.

How does Medpace compare to IQVIA?

Medpace (NASDAQ:MEDP) and IQVIA (NYSE:IQV) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

78.0% of Medpace shares are held by institutional investors. Comparatively, 89.6% of IQVIA shares are held by institutional investors. 20.5% of Medpace shares are held by insiders. Comparatively, 1.7% of IQVIA shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Medpace presently has a consensus price target of $467.08, suggesting a potential upside of 1.50%. IQVIA has a consensus price target of $222.56, suggesting a potential upside of 32.37%. Given IQVIA's stronger consensus rating and higher possible upside, analysts plainly believe IQVIA is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20
IQVIA	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

IQVIA has higher revenue and earnings than Medpace. IQVIA is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	5.19	$451.12M	$15.91	28.93
IQVIA	$16.31B	1.72	$1.36B	$8.07	20.84

Medpace has a net margin of 17.19% compared to IQVIA's net margin of 8.33%. Medpace's return on equity of 120.89% beat IQVIA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.19%	120.89%	24.79%
IQVIA	8.33%	30.50%	6.53%

Medpace has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, IQVIA has a beta of 1.21, indicating that its share price is 21% more volatile than the broader market.

In the previous week, IQVIA had 1 more articles in the media than Medpace. MarketBeat recorded 10 mentions for IQVIA and 9 mentions for Medpace. IQVIA's average media sentiment score of 0.96 beat Medpace's score of 0.93 indicating that IQVIA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IQVIA	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IQVIA beats Medpace on 10 of the 17 factors compared between the two stocks.

How does Medpace compare to Waste Connections?

Waste Connections (NYSE:WCN) and Medpace (NASDAQ:MEDP) are both large-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

Medpace has a net margin of 17.19% compared to Waste Connections' net margin of 10.97%. Medpace's return on equity of 120.89% beat Waste Connections' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waste Connections	10.97%	16.49%	6.45%
Medpace	17.19%	120.89%	24.79%

In the previous week, Waste Connections had 4 more articles in the media than Medpace. MarketBeat recorded 13 mentions for Waste Connections and 9 mentions for Medpace. Medpace's average media sentiment score of 0.93 beat Waste Connections' score of 0.65 indicating that Medpace is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waste Connections	6 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Medpace	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waste Connections currently has a consensus price target of $202.84, indicating a potential upside of 31.69%. Medpace has a consensus price target of $467.08, indicating a potential upside of 1.50%. Given Waste Connections' stronger consensus rating and higher possible upside, research analysts plainly believe Waste Connections is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waste Connections	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.95
Medpace	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20

Waste Connections has a beta of 0.51, suggesting that its stock price is 49% less volatile than the broader market. Comparatively, Medpace has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market.

86.1% of Waste Connections shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 0.3% of Waste Connections shares are held by company insiders. Comparatively, 20.5% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Waste Connections has higher revenue and earnings than Medpace. Medpace is trading at a lower price-to-earnings ratio than Waste Connections, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waste Connections	$9.47B	4.13	$1.08B	$4.10	37.57
Medpace	$2.53B	5.19	$451.12M	$15.91	28.93

Summary

Waste Connections beats Medpace on 9 of the 17 factors compared between the two stocks.

Get Medpace News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MEDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MEDP vs. The Competition

Export

Metric	Medpace	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$13.14B	$8.76B	$6.43B	$12.60B
Dividend Yield	N/A	1.73%	2.68%	5.81%
P/E Ratio	28.93	24.73	24.75	24.42
Price / Sales	5.19	16.61	530.01	108.93
Price / Cash	27.05	102.97	45.07	55.09
Price / Book	28.23	5.64	10.80	6.58
Net Income	$451.12M	$179.69M	$3.57B	$337.17M
7 Day Performance	-1.53%	1.96%	0.73%	0.83%
1 Month Performance	9.09%	4.19%	1.35%	3.27%
1 Year Performance	48.76%	6.36%	29.31%	36.05%

Medpace Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MEDP Medpace	2.3039 of 5 stars	$460.20 flat	$467.08 +1.5%	+52.0%	$13.14B	$2.53B	28.93	6,200	Positive News
EHC Encompass Health	4.7935 of 5 stars	$99.13 -2.3%	$143.86 +45.1%	-18.3%	$10.07B	$5.94B	16.55	42,000	Positive News
ELV Elevance Health	4.53 of 5 stars	$401.19 -0.7%	$416.11 +3.7%	+3.5%	$87.75B	$199.13B	17.06	97,100	Positive News
HIMS Hims & Hers Health	3.0238 of 5 stars	$30.10 +12.2%	$28.70 -4.6%	-42.0%	$6.21B	$2.35B	N/A	2,442	Analyst Forecast Insider Trade Gap Up
IQV IQVIA	4.5761 of 5 stars	$178.07 -1.9%	$224.13 +25.9%	+8.7%	$30.29B	$16.31B	22.07	93,000	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MEDP) was last updated on 6/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Medpace (MEDP) Competitors

MEDP vs. EHC, ELV, HIMS, IQV, and WCN

How does Medpace compare to Encompass Health?

Summary

How does Medpace compare to Elevance Health?

Summary

How does Medpace compare to Hims & Hers Health?

Summary

How does Medpace compare to IQVIA?

Summary

How does Medpace compare to Waste Connections?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEDP vs. The Competition

Medpace Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Medpace (MEDP) Competitors

MEDP vs. EHC, ELV, HIMS, IQV, and WCN

How does Medpace compare to Encompass Health?

Which has preferable earnings and valuation, EHC or MEDP?

Do analysts rate EHC or MEDP?

Do institutionals & insiders hold more shares of EHC or MEDP?

Does the media favor EHC or MEDP?

Which has more volatility and risk, EHC or MEDP?

Is EHC or MEDP more profitable?

Summary

How does Medpace compare to Elevance Health?

Which has higher earnings & valuation, ELV or MEDP?

Do analysts recommend ELV or MEDP?

Does the media refer more to ELV or MEDP?

Do insiders and institutionals hold more shares of ELV or MEDP?

Which has more volatility & risk, ELV or MEDP?

Is ELV or MEDP more profitable?

Summary

How does Medpace compare to Hims & Hers Health?

Which has more volatility and risk, MEDP or HIMS?

Do insiders & institutionals have more ownership in MEDP or HIMS?

Is MEDP or HIMS more profitable?

Which has preferable earnings & valuation, MEDP or HIMS?

Do analysts recommend MEDP or HIMS?

Does the media refer more to MEDP or HIMS?

Summary

How does Medpace compare to IQVIA?

Do institutionals & insiders hold more shares of MEDP or IQV?

Do analysts rate MEDP or IQV?

Which has higher earnings & valuation, MEDP or IQV?

Is MEDP or IQV more profitable?

Which has more risk & volatility, MEDP or IQV?

Does the media prefer MEDP or IQV?

Summary

How does Medpace compare to Waste Connections?

Is WCN or MEDP more profitable?

Does the media favor WCN or MEDP?

Do analysts recommend WCN or MEDP?

Which has more risk & volatility, WCN or MEDP?

Do institutionals & insiders believe in WCN or MEDP?

Which has better valuation & earnings, WCN or MEDP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEDP vs. The Competition

Medpace Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools